Healthcare Industry News: HSMN NewsFeed
News Release - January 21, 2019
Varian Installs Gantry for ProBeam Compact Proton Therapy System at New Treatment Center in SingaporePALO ALTO, Calif. and SINGAPORE, Jan. 21, 2019 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced the installation of the gantry for the Varian ProBeam® Compact single-room proton therapy system at the new oncology center at Biopolis, an international biomedical research hub in Singapore. The gantry is a core piece of equipment of the ProBeam proton therapy system, and its installation is a key milestone for every new proton therapy center. Varian is partnering with Proton Therapy Pte., Ltd. for the installation. Varian will also provide its Eclipse™ treatment planning system training environment for use by Proton Therapy Pte., Ltd. at its new Advanced Medicine Training Centre.
The Varian ProBeam Compact system is a single-room system equipped with a 360-degree gantry for intensity modulated proton therapy (IMPT). The ProBeam system also consists of a superconducting cyclotron, and high-speed pencil-beam scanning. The system's integrated cone beam CT provides accurate patient positioning based on high quality anatomical images with excellent soft tissue resolution. The system can also provide clinicians a viable path to potential next-generation treatments such as Flash therapy. In combination with ARIA® oncology information system and Eclipse™ treatment planning system, the ProBeam system enables an efficient adaptive workflow.
"We are pleased to have achieved this important milestone in the construction of this new oncology center in Singapore," said Kolleen Kennedy, president, Proton Solutions and chief growth officer, Varian. "We look forward to the continuing partnership with Proton Therapy Pte to complete the construction and equipment installation for the first Compact proton system in Southeast Asia and expand access to this advanced cancer treatment technology in the region."
"It is exciting to see the installation of the ProBeam gantry and realize we are yet another step closer to making this cancer treatment technology available to many more patients," said Dr. Djeng Shih Kien, chairman, Proton Therapy Pte., Ltd. "Once operational, this new oncology center will be able to offer highly precise proton therapy treatment and have the opportunity to positively impact many patient lives."
Varian is a leader in developing and delivering cancer care solutions and is focused on creating a world without fear of cancer. Headquartered in Palo Alto, California, Varian employs approximately 7,000 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
About Proton Therapy Pte. Ltd.
Proton Therapy Pte., Ltd. will provide proton beam therapy treatment in Singapore. It is part of a new oncology center that is located at the Biopolis, Singapore. The new oncology center will include a comprehensive diagnostic center providing both imaging and laboratory services using advance medical technologies. Its training facility, Advanced Medicine Training Centre will provide the necessary training to the specialists in this part of the world. For more information, search proton.sg.
Source: Varian Medical Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsVarian Discloses First Preclinical Results of Potential Major Breakthrough in Cancer Treatment
Varian and Tata Trusts Sign Framework Agreement for Advanced Cancer Care Solutions to Address Growing Need in India
First Cancer Patients in Taiwan Treated with Varian HyperArc High-Definition Radiotherapy